With nearly a quarter of the U.S. population vaccinated and vaccines continuing to roll out across the country, Americans are eagerly anticipating an end to the […]
Copanlisib plus rituximab (C+R) reduces disease progression or death in patients with relapsed indolent non-Hodgkin lymphoma (iNHL), according to a study presented during Week 1 of […]
In the case of pregnant mothers with an adverse diagnosis on the health of their child, medical preparation to know how to convey said information should […]